eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 08/12/2011
SPC Boots Blocked Nose Relief 0.05% w/v Nasal Spray


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Boots Blocked Nose Relief 0.05% w/v Nasal Spray


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient

%w/v

Oxymetazoline hydrochloride

0.05%


Go to top of the page
3. PHARMACEUTICAL FORM

Nasal Spray


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the fast relief of stuffy noses due to head colds and hayfever.


Go to top of the page
4.2 Posology and method of administration
Adults and children over 12 years

1-2 sprays up each nostril every 6-8 hours.

Children under 12 years

Not to be administered to children under 12 years.

Elderly

There is no need for dosage reduction in the elderly.

For nasal administration.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any of the ingredients, patients with cardiovascular disease, hyperthyroidism, angle closure glaucoma or prostatic enlargement.


Go to top of the page
4.4 Special warnings and precautions for use

Keep away from the eyes.

Not to be used for children under 12 years without medical advice.

The spray should not be used in excess of the stated dosage nor for longer than seven days without medical advice.

Keep all medicines out of the reach of children.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Boots Nasal Spray should not be given to patients being treated with monoamine oxidase inhibitors or within 14 days of ceasing such treatment.


Go to top of the page
4.6 Pregnancy and lactation

The safety of Boots Nasal Spray during pregnancy and lactation has not been established, but is not thought to constitute a hazard during these periods.


Go to top of the page
4.7 Effects on ability to drive and use machines

No adverse effects known.


Go to top of the page
4.8 Undesirable effects

Occasionally may cause local irritation and dryness of the mouth and throat. Prolonged use may cause rebound congestion and rhinitis medicamentosa.


Go to top of the page
4.9 Overdose

Overdosage may give rise to local irritation and rebound congestion. Treatment need only be symptomatic.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Oxymetazoline hydrochloride is a sympathomimetic amine having vasoconstrictor properties which are utilised in the relief of nasal congestion.


Go to top of the page
5.2 Pharmacokinetic properties

Oxymetazoline enters tissues rapidly and local vasoconstriction is normally achieved within 5-10 minutes of intranasal administration. The full effect lasts for 5-6 hours and then gradually subsides over the next 6 hours. Plasma half-life is 5-8 days with 30% of any absorbed drug being excreted in the urine unchanged and 10% being excreted in the faeces.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Monosodium phosphate fine cryst

Disodium phosphate cryst

Methyl hydroxybenzoate

Cetrimide

Levomenthol natural

Or Levomenthol synthetic

Camphor racemic

Eucalyptol

Alcohol 96%

Purified water


Go to top of the page
6.2 Incompatibilities

Not applicable


Go to top of the page
6.3 Shelf life

18 months


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

A 22ml polypropylene bottle with a polythene plug and elongated nozzle dip tube fitted with a wadless polythene cap that fits the elongated nozzle.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham

NG2 3AA

Trading as: BCM


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00014/0292


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

24 July 1989


Go to top of the page
10. DATE OF REVISION OF THE TEXT

July 2011



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/12004/SPC/


Active Ingredients/Generics

 
   oxymetazoline hydrochloride